| Literature DB >> 32801551 |
Nadezhda Sachivkina1, Ekaterina Lenchenko2, Dmitri Blumenkrants2, Alfia Ibragimova3, Olga Bazarkina4.
Abstract
BACKGROUND AND AIM: Candida albicans is a dimorphic fungus that has both yeast and filamentous forms. It is part of the normal flora in the oral and genital areas of mammals. One factor for the pathogenicity of C. albicans is its ability to switch from yeast to hyphae. The hyphal form adheres and penetrates tissues more readily than the yeast form and produces biofilms that are associated with chronic infection. Biofilms are protective niches that enable microorganisms to be more resistant to antibiotic treatment, thus allowing for persistent infection. The first stage in the transition from yeast to hyphae involves the formation of a germ tube, and this transition is triggered by interactions with host cells. Germ tube formation is dependent on serum, pH, temperature, and quorum-sensing molecules (QSMs). Farnesol, which is a QSM in C. albicans, can prevent yeast to hyphae conversion and inhibits the growth of fungal biofilm. Lyticase is a synergistic enzyme complex that catalyzes yeast cell lysis by b-1,3-glucanase and is a highly specific alkaline protease that produces protoplasts or spheroplasts. This study investigated the effect of farnesol and lyticase on the formation of C. albicans biofilms.Entities:
Keywords: Candida albicans; HiCrome Candida Agar; antimycotic activity; biofilms; enzyme activities; farnesol; hemolytic activity; lyticase; optical density; quorum sensing
Year: 2020 PMID: 32801551 PMCID: PMC7396346 DOI: 10.14202/vetworld.2020.1030-1036
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Phenotypic characteristics of Candida albicans.
| Morphological characteristics | Colony characteristics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sabouraud dextrose broth | Sabouraud dextrose agar | HiCrome candida agar | Hemolytic activities | ||||||||
| Spherical or oval yeast chlamydospores hyphae pseudohyphae hyphal germ tubes | Microfluid opacity, membrane, incoherent precipitate | Smooth, convex, white, soft texture | Colonies of a light-green color | ||||||||
| Urease | Melibiose | Lactose | Maltose | Sucrose | Galactose | Cellobiose | Inositol | Xylose | Dulcitol | Raffinose | Trehalose |
| − | − | − | + | + | + | − | − | + | − | − | + |
Figure-1The intensity of Candida albicans biofilms, 37°C 48 h – experiment (I): Yeast and mycelial forms forming the aggregation of microorganisms, covered by a thin layer of blue intercellular matrix. Staining with a methylene blue, optical microscopy 200×.
Figure-2The intensity of the formation of biofilms of Candida albicans, 37°C 48 h – experience (I): Isolated structures separated by matrix voids. Staining with a methylene blue, optical microscopy 200×.
Figure-3The intensity of the formation of biofilms of Candida albicans, 37°C 48 h – experiment (I): Architectonics of a grown biofilm. Coaggregation of yeast and mycelial forms is combined with an exocellular matrix. The long branched hyphal forms are composing dense structures from pseudomycelia. Staining with a methylene blue, optical microscopy 100×.
Figure-4The intensity of the formation of Candida albicans biofilms, 37°C 48 h – experiment (I): Microcolony – coaggregation of microorganisms united by an exocellular matrix more pronounced in the central part and much thinner on the periphery. Staining with a methylene blue, optical microscopy 100×.
Changes in the colony of Candida albicans biofilms after exposure to antifungal drugs.
| Groups | Changes in the colony structures (≥90.0% in the microscope POV) | ||
|---|---|---|---|
| Solitary cells and clusters | Microcolonies | Mycelial forms | |
| I – | + | + | + |
| II – | + | – | – |
| III – | + | – | – |
| IV – | + | – | – |
+ - presence, – - absence. Candida albicans=C. albicans
Analysis of the optical density of biofilms.
| Microorganism culture | Optical density (OD) | |||
|---|---|---|---|---|
| Control (ODc) | Exp (ODs) | Δ (ODs–ODc) | Intensity (I) | |
| 0.099±0.03 | 0.503±0.06 | 0.404±0.09 | ≥0.4 | |
≤0.1 – non-biofilm producing microorganisms, ≤0.2 – weak biofilm producers, ≤ 0.3 – medium biofilm producers, ≥0.4 – strong biofilm producers
Analysis of the optical density of biofilms of microorganisms when exposed to the Farnesol.
| Medicine concentration, μM | Optical density (OD) | |||
|---|---|---|---|---|
| Control (ODc) | Exp (ODs) | Δ (ODs–ODc) | Intensity ( | |
| 100 | 0.096±0.03 | 0.395±0.06 | 0.299±0.09 | ≤0.3 |
| 200 | 0.099±0.05 | 0.372±0.03 | 0.273±0.08 | ≤0.3 |
| 400 | 0.098±0.01 | 0.365±0.07 | 0.267±0.09 | ≤0.3 |
≤0.1 – non-biofilm producing microorganisms; ≤0.2 – weak biofilm producers; ≤0.3 – medium biofilm producers; ≥0.4 – strong biofilm producers
Analysis of the optical density of biofilms of microorganisms when exposed to the Lyticase.
| Medicine concentration, units | Optical density (OD) | |||
|---|---|---|---|---|
| Control (ODc) | Exp (ODs) | Δ (ODs–ODc) | Intensity ( | |
| 250 | 0.099±0.08 | 0.371±0.09 | 0.272±0.17 | ≤0.3 |
| 500 | 0.096±0.02 | 0.335±0.01 | 0.239±0.03 | ≤0.3 |
| 1000 | 0.098±0.09 | 0.299±0.05 | 0.201±0.14 | ≤0.3 |
≤0.1 – non-biofilm producing microorganisms, ≤0.2 – weak biofilm producers, ≤0.3 – medium biofilm producers, ≥0.4 – strong biofilm producers
Analysis of the optical density of biofilms of microorganisms when exposed to the Farnesol and Lyticase.
| Medicine concentration, μM – Farnesol units - Lyticase | Optical density (OD) | |||
|---|---|---|---|---|
| Control (ODc) | Exp (ODs) | Δ (ODs–ODc) | Intensity ( | |
| 100 250 | 0.099±0.02 | 0.259±0.09 | 0.160±0.11 | ≤0.2 |
| 200 500 | 0.098±0.04 | 0.219±0.01 | 0.121±0.05 | ≤0.2 |
| 400 1000 | 0.098±0.07 | 0.200±0.06 | 0.102±0.09 | ≤0.2 |
≤0.1 – non-biofilm producing microorganisms, ≤0.2 – weak biofilm producers, ≤0.3 – medium biofilm producers, ≥0.4 – strong biofilm producers